Pregnancy Planning With IBD: A Six-Month Preconception Checklist

Planning a pregnancy when you live with inflammatory bowel disease involves more preparation than a typical preconception timeline, and most of the important work happens before you start trying to conceive. Crohn's disease and ulcerative colitis are chronic conditions whose effect on pregnancy depends heavily on how well they are controlled at the moment of conception, so the months beforehand are when you and your care team can set the stage for a healthier outcome. This six-month preconception checklist organizes pregnancy planning with IBD into a sequence of concrete steps, from confirming remission to coordinating specialists, so you can walk into each appointment prepared. Every clinical decision here belongs to you and your physicians, and this checklist is a way to structure those conversations rather than a substitute for them.

Six Months Out: Confirm Stable Remission

The single most useful thing you can do before trying to conceive is confirm that your disease is quiet and has stayed that way. The Crohn's & Colitis Foundation advises that the best time to become pregnant is when IBD has been in remission for at least three to six months and you are off steroids, because conceiving during a flare raises the risk of miscarriage, premature delivery, and low birth weight. Data from the PIANO registry point to active disease itself, rather than medication, as the main driver of adverse pregnancy outcomes. The AGA-led IBD Parenthood Project similarly frames an IBD flare as one of the greatest known risks to pregnancy. If your remission is recent or uncertain, ask your gastroenterologist whether objective testing, such as bloodwork, stool markers, or endoscopy, would help confirm it before you begin.

Five Months Out: Review Every Medication With Your GI

Bring a complete list of everything you take to your gastroenterologist and ask which items need to change before conception. Guidance is specific about the drugs that require action. The Crohn's & Colitis Foundation notes that methotrexate should be discontinued at least three months before conception and that tofacitinib should be stopped roughly a week beforehand when another option exists. The recent Global Consensus Statement on IBD in pregnancy advises stopping methotrexate one to three months before conception and discontinuing JAK inhibitors and S1P modulators unless they are essential for maternal health. Methotrexate carries this caution because it interferes with folic acid metabolism and has been linked to a pattern of birth defects with first-trimester exposure. Many other therapies, including anti-TNF agents, thiopurines, and aminosalicylates, are generally described in these guidelines as reasonable to continue, but that judgment belongs to your physician.

Four Months Out: Understand the Evidence Behind Continuing Therapy

Fear of harming a pregnancy leads some people to stop effective treatment, which is often the riskier choice. The prospective PIANO registry followed roughly a thousand women with IBD and found that exposure to biologics or thiopurines did not increase congenital malformations, spontaneous abortion, preterm birth, low birth weight, or first-year infections. The PIANO study has also examined how different medications cross the placenta and how anti-TNF and thiopurine exposure affects infant immune development and vaccine responses. Guidelines reflect this evidence by supporting continuation of most maintenance therapy through pregnancy to protect remission. The Global Consensus Statement lists anti-TNF agents, thiopurines, aminosalicylates, anti-integrins, and IL-23 and IL-12/23 therapies among treatments considered compatible with continuation. Use this appointment to understand the reasoning so any adjustments feel informed rather than fearful.

Three Months Out: Folic Acid, Nutrition, and Lab Work

Preconception nutrition deserves attention several months ahead. The CDC recommends 400 micrograms of folic acid daily for anyone who could become pregnant, ideally starting at least one month before conception, to reduce the risk of neural tube defects. This matters especially in IBD, where absorption can be affected and where the Crohn's & Colitis Foundation advises people taking sulfasalazine to increase folate intake to 2 milligrams daily because the drug impairs folate absorption. The Global Consensus Statement recommends optimizing nutritional status and screening for micronutrient deficiencies before conception. Ask your team whether checking iron, vitamin B12, vitamin D, and folate levels would be worthwhile given your disease history and diet, and whether a prenatal vitamin or a higher folic acid dose is appropriate for you specifically.

Two Months Out: Build Your Care Team

Pregnancy with IBD works best when your specialists communicate. The IBD Parenthood Project, a collaboration among the AGA, the Society for Maternal-Fetal Medicine, the Crohn's & Colitis Foundation, and Girls With Guts, recommends coordinated care and suggests involving a maternal-fetal medicine subspecialist, an obstetrician with additional training in higher-risk pregnancies. The Global Consensus Statement treats pregnancies in women with IBD as high risk and calls for collaboration among gastroenterologists, obstetricians, maternal-fetal medicine specialists, and surgeons where relevant. Use these weeks to identify an obstetric provider comfortable with chronic illness, confirm your gastroenterologist will stay involved throughout pregnancy, and ask each office how they prefer to share records so nothing falls through the cracks once you conceive.

One Month Out: Prepare Your Questions and a Written Summary

By the final month before trying, gather your history into one place so every conversation starts from the same facts. A concise summary of your diagnosis, past disease activity, surgeries, current medications, and recent lab and imaging results helps your gastroenterologist and obstetric team plan together. Good questions to raise include how your specific medications will be managed across each trimester, what would trigger a change in your treatment plan, and how flares would be monitored and handled during pregnancy. The Crohn's & Colitis Foundation cautions against starting new medications right at conception, which is another reason to settle your regimen in advance. Preconception planning with a chronic illness rewards organization, and a disease that is quiet, a medication plan you understand, and a care team that talks to one another give you the strongest foundation to begin from.